Early-onset atrial fibrillation and the prevalence of rare variants in cardiomyopathy and arrhythmia genes

ZT Yoneda, KC Anderson, JA Quintana… - JAMA …, 2021 - jamanetwork.com
Importance Early-onset atrial fibrillation (AF) can be the initial manifestation of a more
serious underlying inherited cardiomyopathy or arrhythmia syndrome. Objective To examine …
被引用次数：97 相关文章
[HTML] nih.gov

[HTML][HTML] Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes

ZT Yoneda, KC Anderson, JA Quintana… - JAMA …, 2021 - ncbi.nlm.nih.gov
Results Among 1293 participants (934 [72.2%] male; median [interquartile range] age at
enrollment, 56 [48-61] years; median [interquartile range] age at AF diagnosis, 50 [41-56] …

Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes

ZT Yoneda, KC Anderson, JA Quintana… - JAMA …, 2021 - pubmed.ncbi.nlm.nih.gov
Importance Early-onset atrial fibrillation (AF) can be the initial manifestation of a more
serious underlying inherited cardiomyopathy or arrhythmia syndrome. Objective To examine …

Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes.

ZT Yoneda, KC Anderson, JA Quintana… - JAMA …, 2021 - europepmc.org
Results Among 1293 participants (934 [72.2%] male; median [interquartile range] age at
enrollment, 56 [48-61] years; median [interquartile range] age at AF diagnosis, 50 [41-56] …

[引用][C] Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes

ZT Yoneda, KC Anderson, JA Quintana, MJ O'Neill… - JAMA Cardiology, 2021 - cir.nii.ac.jp
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and
Arrhythmia Genes | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes.

ZT Yoneda, KC Anderson, JA Quintana… - JAMA …, 2021 - europepmc.org
Results Among 1293 participants (934 [72.2%] male; median [interquartile range] age at
enrollment, 56 [48-61] years; median [interquartile range] age at AF diagnosis, 50 [41-56] …